Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation. [electronic resource]
- Circulation Nov 1997
- II-154-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0009-7322
Adult Aged Anticholesteremic Agents--therapeutic use Blood Component Removal Cholesterol--blood Coronary Disease--prevention & control Female Fibrinogen--analysis Heart Transplantation--adverse effects Humans Male Middle Aged Simvastatin--therapeutic use